Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $15.46 USD
Change Today 0.00 / 0.00%
Volume 0.0
RDLSF On Other Exchanges
EN Amsterdam
New York
As of 8:10 PM 01/21/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Radarweg 29

Amsterdam, 1043 NX


Phone: 31 20 485 2222

Fax: 31 20 485 2032

RELX NV provides information solutions for professional customers across industries. The company’s principal operations are in North America and Europe. Segments The company operates in four market segments: Scientific, Technical & Medical; Risk & Business Information; Legal; and Exhibitions. Scientific, Technical & Medical segment This segment provides information and tools to help its customers improve scientific and healthcare outcomes. The company provides scientific, technical, and medical information serving scientists, health professionals, and students worldwide. The company has a global business with principal operations in Amsterdam, Beijing, Boston, Chennai, Delhi, London, Madrid, Munich, New York, Oxford, Paris, Philadelphia, Rio de Janeiro, St. Louis, San Diego, Singapore, and Tokyo. The company serves the needs of the science, technology, and medical markets by publishing primary research, reference, and education content, as well as by providing a range of database and workflow solutions. Its customers are scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, allied health professionals, and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations, and governments. In 2014, the company expanded the Lancet collection, adding new titles, such as The Lancet Psychiatry, The Lancet HIV, and The Lancet Haematology. The company also provides authoritative professional reference content. Primary titles include works, such as Gray’s Anatomy, Nelson’s Pediatrics, and Netter’s Atlas of Human Anatomy. The company’s clinical reference platform, ClinicalKey, provides physicians with access to the company and third-party reference and evidence-based medical content in a single integrated site. ClinicalKey is continuing to improve and is accessed by approximately 2,000 institutions. In medical education, the company serves students of medicine, nursing, and allied health professions through print and electronic books, as well as electronic solutions. HESI, an online testing and remediation solution designed to help students of nursing and allied health professionals, conducted approximately 700,000 tests in 2014. The company’s database and workflow products provide a range of tools and solutions for professionals in the science, technical, and medical fields. Customers include academic and corporate researchers, research administrators, and healthcare professionals. For academic and corporate researchers, major products include Scopus, Reaxys, and Knovel. Scopus is the major abstract and citation database of research literature in the world, with approximately 56 million abstract and bibliographic information records from approximately 21,000 peer-reviewed journals and 5,000 international publishers. Reaxys is a major solution for synthetic chemists, integrating chemical reaction and compound data searching with synthesis planning. Knovel provides a range of Web-based productivity tools for the engineering community, integrating technical information with analytics and search to deliver answers and drive innovation. The company serves academic and government research administrators through its Elsevier Research Intelligence suite of products. Leveraging bibliometric data from Scopus and other data types, SciVal, helps institutions to establish, execute, and evaluate research strategies. Pure is a research information management system, which enables evidence-based research management decisions, promotes collaboration, simplifies administration, and optimizes impact. The company’s Analytical Services team provides unbiased analysis on research performance by combining data sources with technical and research metrics expertise. SciVal Funding assists researchers and institutions in identifying grants that are relevant in their research areas. For healthcare professionals, the company develops products to deliver patient-specific solutions at the point of care to improve patient outcomes. Its clinical solutions include ExitCare, which provides pati


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDLSF:US $15.46 USD 0.00

RDLSF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RDLSF.
View Industry Companies

Industry Analysis


Industry Average

Valuation RDLSF Industry Range
Price/Earnings 24.4x
Price/Sales -- Not Meaningful
Price/Book 10.4x
Price/Cash Flow 22.4x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RELX NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at